Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore effective ways to increase your cash back earnings on credit cards. Unlock potential savings with smart strategies.
24,913 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A new CBO forecast warns that social security’s trust fund could be empty by 2032, triggering automatic cuts that wou...
CFOs and boards are confronting a pivotal moment: how well they govern AI agents to protect value and manage risk. Th...
A viral post about a high school student’s plan to depend on a future spouse has sparked a broader look at financial ...
A Florida biologist and state agency reach a $485,000 settlement over her firing tied to social media comments about ...
Five weeks after Vanguard split three ETFs, VGT led the gauges, turning a post-split move into a meaningful performan...
Microsoft is shifting toward building its own AI backbone. This article explores what that means for investors, how i...
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Markets react to kevin warsh’s first meeting as Fed chair, with stocks rising, bond yields fluctuating and traders we...
A data-driven model now sees roughly 36% upside for Qualcomm stock within a year, even after a choppy period around i...
June’s job gains slowed dramatically to 57,000, with May and April revisions lowering earlier totals. The economy dis...
A real estate rally this year is being led by data-center REITs powering AI, pushing the sector to outsized gains eve...